Our top pick for
Infobird Co. Ltd is a software-application business based in the US. Infobird CoLtd shares (IFBD) are listed on the NASDAQ and all prices are listed in US Dollars. Infobird CoLtd employs 305 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$2.04|
|52-week range||$2.01 - $11.25|
|50-day moving average||$2.39|
|200-day moving average||$3.29|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.21|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-18)||-3.77%|
|1 month (2021-09-24)||-17.74%|
|3 months (2021-07-23)||-36.05%|
|6 months (2021-04-23)||-51.66%|
|1 year (2020-10-21)||N/A|
|2 years (2019-10-21)||N/A|
|3 years (2018-10-21)||N/A|
|5 years (2016-10-21)||N/A|
Valuing Infobird CoLtd stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Infobird CoLtd's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Infobird CoLtd's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Infobird CoLtd shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Infobird CoLtd's P/E ratio is best considered in relation to those of others within the software-application industry or those of similar companies.
Infobird CoLtd's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.5 million.
The EBITDA is a measure of a Infobird CoLtd's overall financial performance and is widely used to measure a its profitability.
To put Infobird CoLtd's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$14.5 million|
|Operating margin TTM||30.05%|
|Gross profit TTM||$9.8 million|
|Return on assets TTM||20.15%|
|Return on equity TTM||69.25%|
|Market capitalisation||$52 million|
TTM: trailing 12 months
There are currently 198,687 Infobird CoLtd shares held short by investors – that's known as Infobird CoLtd's "short interest". This figure is 39.6% down from 329,094 last month.
There are a few different ways that this level of interest in shorting Infobird CoLtd shares can be evaluated.
Infobird CoLtd's "short interest ratio" (SIR) is the quantity of Infobird CoLtd shares currently shorted divided by the average quantity of Infobird CoLtd shares traded daily (recently around 157688.0952381). Infobird CoLtd's SIR currently stands at 1.26. In other words for every 100,000 Infobird CoLtd shares traded daily on the market, roughly 1260 shares are currently held short.
To gain some more context, you can compare Infobird CoLtd's short interest ratio against those of similar companies.
However Infobird CoLtd's short interest can also be evaluated against the total number of Infobird CoLtd shares, or, against the total number of tradable Infobird CoLtd shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Infobird CoLtd's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Infobird CoLtd shares in existence, roughly 10 shares are currently held short) or 0.0122% of the tradable shares (for every 100,000 tradable Infobird CoLtd shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Infobird CoLtd.
Find out more about how you can short Infobird CoLtd stock.
We're not expecting Infobird CoLtd to pay a dividend over the next 12 months.
Infobird Co. , Ltd operates as a software-as-a-service (SaaS) provider of artificial intelligence (AI) enabled customer engagement solutions in the People's Republic of China. It offers standard and customized customer relationship management cloud-based services, such as SaaS, and business process outsourcing services to its clients. The company also provides AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to enable its clients monitor, benchmark, and improve the performances of agents; and other services, including software license selling, data analysis, and other professional services. It serves corporate clients in the finance, education, public services, healthcare, and consumer products industries. The company was incorporated in 2020 and is based in Beijing, the People's Republic of China. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.